Stage II Breast Cancer
120 clinical trials · Condition
◉ Watch Stage II Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer (NCT00070057) | National Cancer Institute (NCI) | 2003-04-01 |
| Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer (NCT00049114) | National Cancer Institute (NCI) | 2003-02-01 |
| Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer (NCT00146588) | Craig A. Bunnell, MD, MPH | 2002-04-01 |
| Preoperative Herceptin and Navelbine for Breast Cancer (NCT00148681) | Dana-Farber Cancer Institute | 2001-05-01 |
| Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer (NCT00019643) | National Institutes of Health Clinical Center (CC) | 1999-08-01 |
| Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer (NCT00080613) | Robert H. Lurie Cancer Center |
Track Stage II Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.